In conclusion, inhibition of hedgehog signaling with vismodegib appears to reduce TRAIL-mediated liver injury in a nutrient excess model of NASH, thereby attenuating hepatic inflammation and fibrosis. This evidence concerns the gene TNFSF10 and metabolic dysfunction-associated steatohepatitis.